UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 28, 2009

Accession Number:	0001193125-09-119389
Submission Type:	POS AM
CIK: 0000072444 Company Name: NABI BIOPHARMACEUTICALS File Number: 333-112006